Drug resistance is an important problem hindering malaria elimination in tropical areas. Point mutations in Plasmodium falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes confer resistance to antifolate drug, sulfadoxine-pyrimethamine (SP) while P. falciparum chloroquine-resistant transporter (Pfcrt) genes caused resistance to chloroquine (CQ). Decline in Pfdhfr/Pfdhps and Pfcrt mutations after withdrawal of SP and CQ has been reported. The aim of present study was to investigate the prevalence of Pfdhfr, Pfdhps, and Pfcrt mutation from 2 endemic areas of Thailand. All of 200 blood samples collected from western area (Thai-Myanmar) and southern area (Thai-Malaysian) contained multiple mutations in Pfdhfr and Pfdhps genes. The most prevalent haplotypes for Pfdhfr and Pfdhps were quadruple and double mutations, respectively. The quadruple and triple mutations of Pfdhfr and Pfdhps were common in western samples, whereas low frequency of triple and double mutations was found in southern samples, respectively. The Pfcrt 76T mutation was present in all samples examined. Malaria isolated from 2 different endemic regions of Thailand had high mutation rates in the Pfdhfr, Pfdhps, and Pfcrt genes. These findings highlighted the fixation of mutant alleles causing resistance of SP and CQ in this area. It is necessary to monitor the re-emergence of SP and CQ sensitive parasites in this area.
Citations
Citations to this article as recorded by
Assessing fitness costs in malaria parasites: a comprehensive review and implications for drug resistance management Xyonane Segovia, Bhavya Srivastava, Sergio Serrato-Arroyo, Ashley Guerrero, Silvie Huijben Malaria Journal.2025;[Epub] CrossRef
Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon Pacome V. K. Tchuenkam, Lesley N. Ngum, Innocent M. Ali, Jean Paul K. Chedjou, Akindeh M. Nji, Palmer M. Netongo, Randolph Ngwafor, Peter Thelma N. Niba, Calvino F. Tah, William D. Nana, Germaine Ekoyol, Jude D. Bigoga, Dorothy F. Ashu, Christopher B. Tum Wellcome Open Research.2024; 9: 323. CrossRef
Exploring the Recent Pioneering Developments of Small Molecules in Antimalarial Drug Armamentarium: A Chemistry Prospective Appraisal Tameika Bagratee, Ritika Prawlall, Thabani Ndlovu, Sinqobile Sibisi, Sisa Ndadane, Baji Baba Shaik, Mahesh B. Palkar, Raghavachary Gampa, Rajshekhar Karpoormath Chemistry & Biodiversity.2024;[Epub] CrossRef
In vitro
efficacy of next-generation dihydrotriazines and biguanides against babesiosis and malaria parasites
Pratap Vydyam, Meenal Chand, Shalev Gihaz, Isaline Renard, Gavin D. Heffernan, Laura R. Jacobus, David P. Jacobus, Kurt W. Saionz, Raju Shah, Hong-Ming Shieh, Jacek Terpinski, Wenyi Zhao, Emmanuel Cornillot, Choukri Ben Mamoun, Audrey Odom John Antimicrobial Agents and Chemotherapy.2024;[Epub] CrossRef
Antimalarial drug sulfadoxine induces gametocytogenesis in Plasmodium berghei Wihda Aisarul Azmi, Andita Fitri Mutiara Rizki, Achmad Shidiq, Yenny Djuardi, I Made Artika, Josephine Elizabeth Siregar Malaria Journal.2024;[Epub] CrossRef
Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012–2022 Ruimin Zhou, Suhua Li, Penghui Ji, Shucheng Ruan, Ying Liu, Chengyun Yang, Dan Qian, Zhiquan He, Dan Wang, Deling Lu, Hongwei Zhang, Yan Deng Scientific Reports.2024;[Epub] CrossRef
A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria Adebanjo J. Adegbola, Omotade A. Ijarotimi, Akaninyene E. Ubom, Bukola A. Adesoji, Olajide E. Babalola, Emma F. Hocke, Helle Hansson, Andria Mousa, Oluseye O. Bolaji, Michael Alifrangis, Cally Roper Malaria Journal.2023;[Epub] CrossRef
Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds S. Maheen Abdul Rahman, Jasvinder Singh Bhatti, Suresh Thareja, Vikramdeep Monga European Journal of Medicinal Chemistry.2023; 259: 115699. CrossRef
Genetic polymorphisms of pvdhfr and pvdhps genes of Plasmodium vivax were investigated in 83 blood samples collected from patients in the Philippines, Bangladesh, and Nepal. The SNP-haplotypes of the pvdhfr gene at the amino acid positions 13, 33, 57, 58, 61, 117, and 173, and that of the pvdhps gene at the positions 383 and 553 were analyzed by nested PCR-RFLP. Results suggest diverse polymorphic patterns of pvdhfr alone as well as the combination patterns with pvdhps mutant alleles in P. vivax isolates collected from the 3 endemic countries in Asia. All samples carried mutant combination alleles of pvdhfr and pvdhps. The most prevalent combination alleles found in samples from the Philippines and Bangladesh were triple mutant pvdhfr combined with single mutant pvdhps allele and triple mutant pvdhfr combined with double wild-type pvdhps alleles, respectively. Those collected from Nepal were quadruple mutant pvdhfr combined with double wild-type pvdhps alleles. New alternative antifolate drugs which are effective against sulfadoxine-pyrimethamine (SP)-resistant P. vivax are required.
Citations
Citations to this article as recorded by
Molecular surveillance of antifolate drug resistance markers in Plasmodium vivax from Khyber Pakhtunkhwa province, northwest Pakistan Thu Hằng Nguyễn, Hương Giang Lê, Tuấn Cường Võ, Đăng Thùy Dương Nguyễn, Kim Oanh Nguyễn, Minkyoung Cho, Youn-Kyoung Goo, Sahib Gul Afridi, Byoung-Kuk Na Acta Tropica.2025; 264: 107583. CrossRef
Genetic Diversity of Plasmodium vivax Merozoite Surface Protein-3 Alpha and Beta from Diverse Geographic Areas of Thailand Jiraporn Kuesap, Kanchana Rungsihirunrat, Wanna Chaijaroenkul, Mathirut Mungthin Japanese Journal of Infectious Diseases.2022; 75(3): 241. CrossRef
Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites Rini Chaturvedi, Jyoti Chhibber-Goel, Ishika Verma, Sreehari Gopinathan, Suhel Parvez, Amit Sharma International Journal for Parasitology.2021; 51(7): 505. CrossRef
Molecular monitoring of dihydrofolatereductase (dhfr) and dihydropteroatesynthetase (dhps) associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates of Palawan, Philippines Alison Paolo Bareng, Fe Esperanza Espino, Wanna Chaijaroenkul, Kesara Na-Bangchang Acta Tropica.2018; 180: 81. CrossRef
Mutations of pvdhfr and pvdhps genes in vivax endemic-malaria areas in Kota Marudu and Kalabakan, Sabah Umi Rubiah Sastu, Noor Rain Abdullah, Nor Azrina Norahmad, Muhammad Nor Farhan Saat, Prem Kumar Muniandy, Jenarun Jelip, Moizin Tikuson, Norsalleh Yusof, Hasidah Mohd Sidek Malaria Journal.2016;[Epub] CrossRef
Geographic distribution of amino acid mutations in DHFR and DHPS in Plasmodium vivax isolates from Lao PDR, India and Colombia Naowarat Saralamba, Supatchara Nakeesathit, Mayfong Mayxay, Paul N. Newton, Lyda Osorio, Jung-Ryong Kim, Nicholas J. White, Nicholas P. J. Day, Arjen M. Dondorp, Mallika Imwong Malaria Journal.2016;[Epub] CrossRef
The use of sulfadoxine and pyrimethamine (SP) for treatment of vivax malaria is uncommon in most malarious areas, but Plasmodium vivax isolates are exposed to SP because of mixed infections with other Plasmodium species. As P. vivax is the most prevalent species of human malaria parasites in Iran, monitoring of resistance of the parasite against the drug is necessary. In the present study, 50 blood samples of symptomatic patients were collected from 4 separated geographical regions of south-east Iran. Point mutations at residues 57, 58, 61, and 117 were detected by the PCR-RFLP method. Polymorphism at positions 58R, 117N, and 117T of P. vivax dihydrofolate reductase (Pvdhfr) gene has been found in 12%, 34%, and 2% of isolates, respectively. Mutation at residues F57 and T61 was not detected. Five distinct haplotypes of the Pvdhfr gene were demonstrated. The 2 most prevalent haplotypes were F57S58T61S117 (62%) and F57S58T61N117 (24%). Haplotypes with 3 and 4 point mutations were not found. The present study suggested that P. vivax in Iran is under the pressure of SP and the sensitivity level of the parasite to SP is diminishing and this fact must be considered in development of malaria control programs.
Citations
Citations to this article as recorded by
Molecular evaluation of pvdhfr and pvmdr-1 mutants in Plasmodium vivax isolates after treatment with sulfadoxine/pyrimethamine and chloroquine in Iran during 2001–2016 Mahdi Parsaei, Ahmad Raeisi, Adel Spotin, Abbas Shahbazi, Mahmoud Mahami-Oskouei, Teimour Hazratian, Alireza Salimi Khorashad, Jalal Zaman, Ahad Bazmani, Sedighe Sarafraz Infection, Genetics and Evolution.2018; 64: 70. CrossRef
Mutational Analysis of Plasmodium vivax dhfr Gene Among Cases in South East of Iran Hadi Mirahmadi, Maryam Rafee, Jalal Zaman, Ahmad Mehravaran, Reza Shafiei Jundishapur Journal of Microbiology.2017;[Epub] CrossRef
MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN Khojasteh SHARIFI-SARASIABI, Ali HAGHIGHI, Bahram KAZEMI, Niloofar TAGHIPOUR, Ehsan Nazemalhosseini MOJARAD, Latif GACHKAR Revista do Instituto de Medicina Tropical de São Paulo.2016;[Epub] CrossRef
First
Prev
